Invited Presenter: Jane Speight, MSc, PhD, CPsychol, FBPsS – The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria and Deakin University
CE/CME Hours: 0.0
5:00 PM – 6:30 PM CT
Coordinating Body, Local Networking Group, and Communities of Interest Networking Reception
5:00 PM – 6:30 PM CT
NE01 - Coordinating Body, Local Networking Group, and Communities of Interest Networking Reception
Location: Great Hall Foyer
CE/CME Hours: 0.0
Friday, August 9, 2024
8:00 AM – 9:30 AM CT
President's Address & General Session: The Jaw-Dropping, Undeniable Power of Encouragement; The People Side of Performance
8:00 AM – 9:30 AM CT
GS01 - President's Address & General Session: The Jaw-Dropping, Undeniable Power of Encouragement; The People Side of Performance
On-DemandPsychosocial / Behavioral Health
CE/CME Hours: .75
7:00 AM – 4:00 PM CT
Registration
7:00 AM – 4:00 PM CT
Registration
Location: Lobby A
8:00 AM – 9:30 AM CT
President's Address & General Session: How Many Mondays Do You Have Left? Make Them Count!
8:00 AM – 9:30 AM CT
GS01 - President's Address & General Session: How Many Mondays Do You Have Left? Make Them Count!
P103 - Efficacy and Safety of Sotagliflozin, a Dual Sodium-Glucose Cotransporter 1-2 Inhibitor, in Patients with Type 1Diabetes and Chronic Kidney Disease: A Post-Hoc Analysis of the inTandem Studies
P104 - Impact of Sotagliflozin, a Dual Sodium-Glucose Cotransporter 1-2 Inhibitor, as Add-on to Inadequately Controlled Basal Insulin-Treated Type 2 Diabetes
P108 - Ongoing Treatments with High Concentration Capsaicin Topical System Results in Progressive Pain Reduction for Painful Diabetic Neuropathy: A Retrospective Real-World Analysis
P112 - Once-Weekly Basal Insulin Efsitora Alfa Demonstrates Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With T2D: Results from Phase 2
P312 - Misconceptions and Fragmentation: The State of Diabetes Care in America- A Survey of more than 1500 individuals Living with Diabetes & Wearing Diabetes Devices
P505 - Glycemic Improvement with Use of the Omnipod® 5 Automated Insulin Delivery (AID) System in Adults with Type 2 Diabetes: Results of the SECURE-T2D Pivotal Trial
P528 - Glycemic and CGM Outcomes are Nearly Independent of Frequency of User Engagement with the iLet in the Bionic Pancreas Pivotal Trial and Real-world Setting
P608 - Diabetes Management in Primary Care: A Theoretical Framework
Primary Presenter: Brittany Marks, RN FNP-C BC-ADM – University of Missouri (student), Middle Tennessee State University (Professor), Murfreesboro Medical Clinic (FNP)
The Business of Providing High Quality Care
12:15 PM – 1:15 PM CT
P609 - Interviews of College Students with T1D Regarding Interactions with Endocrinologists